
Palboxen 125mg Capsule
Marketer
Everest Laboratories
Salt Composition
Palbociclib (125mg)
Overview Palboxen 125mg Capsule
Estrogen receptor-positive, HER2-negative metastatic breast cancer is treated with the 125mg Palboxen capsule, administered concurrently with hormonal anticancer agents. For optimal absorption, ingest the capsule with food at the same time each day. Dosage and frequency are determined by your physician based on individual needs and may be adjusted. Adhere strictly to the prescribed regimen; incorrect usage or overdose may lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Common side effects encompass fatigue, alopecia, skin rashes, emesis, and diarrhea. Reduced blood cell counts (leukopenia and anemia), increasing infection risk, are possible. Report any infection symptoms (fever, chills, malaise, bleeding, bruising, epistaxis) immediately. Dizziness may occur; avoid driving or activities requiring alertness if affected. Prior to treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and all concurrent medications (including antibiotics) to your doctor, as drug interactions are possible. Palboxen is contraindicated during pregnancy and lactation. Reliable contraception for both partners is crucial throughout the treatment period to prevent conception.
Primary Ingredients of Palboxen 125mg Capsule
There is no text provided to rewrite. Please provide the text you wish to have rephrased.
Uses of Palboxen 125mg Capsule
Malignant mammary tumor
Major Benefits of Palboxen 125mg Capsule:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest each Palboxen 125mg capsule with a meal.
Common Side effects of Palboxen 125mg Capsule:
- Decreased blood cells (red cells, white cells, and platelets)
- Fatigue
- Hair loss
- Rash
- Vomiting
- Diarrhea
- Nausea
- Decreased appetite
- Infection
- Decreased white blood cell count
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Weakness
- Fever
How to use Palboxen 125mg Capsule:
Administer this medication according to your physician's prescribed dosage and schedule. Consume the Palboxen 125mg Capsule with a meal.
How Palboxen 125mg Capsule works:
Palboxen 125mg capsules function as an anti-cancer agent. Its mechanism involves blocking cyclin-dependent kinases 4 and 6, key proteins driving cellular proliferation. This inhibition halts the cancerous cell growth cycle by interfering with crucial signaling pathways. Specifically, it targets estrogen receptor-positive breast cancers by disrupting their cellular replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Palboxen 125mg Capsules may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Use of Palboxen 125mg Capsules during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Palboxen 125mg capsules are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Palboxen 125mg Capsules, a potential side effect being fatigue in some patients. Therefore, operating vehicles or machinery requires extra care if such fatigue occurs.
KidneySAFE IF PRESCRIBED
Palboxen 125mg capsules can be administered to patients with renal impairment without requiring a change in dosage.
LiverCAUTION
Patients with hepatic impairment should use Palboxen 125mg capsules cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Palboxen 125mg Capsule :
NA
Facts to Know About Palboxen 125mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Piperazine-pyridines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | CDK Inhibitor |
